DE60043823D1 - Chemokine rezeptor - Google Patents
Chemokine rezeptorInfo
- Publication number
- DE60043823D1 DE60043823D1 DE60043823T DE60043823T DE60043823D1 DE 60043823 D1 DE60043823 D1 DE 60043823D1 DE 60043823 T DE60043823 T DE 60043823T DE 60043823 T DE60043823 T DE 60043823T DE 60043823 D1 DE60043823 D1 DE 60043823D1
- Authority
- DE
- Germany
- Prior art keywords
- rezeptor
- chemokine
- methods
- expression
- modulate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15901599P | 1999-10-12 | 1999-10-12 | |
US15921099P | 1999-10-13 | 1999-10-13 | |
US17297999P | 1999-12-20 | 1999-12-20 | |
US17338999P | 1999-12-28 | 1999-12-28 | |
US18662600P | 2000-03-03 | 2000-03-03 | |
PCT/US2000/028067 WO2001027146A2 (en) | 1999-10-12 | 2000-10-10 | Chemokine receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60043823D1 true DE60043823D1 (en) | 2010-03-25 |
Family
ID=27538581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60043823T Expired - Lifetime DE60043823D1 (en) | 1999-10-12 | 2000-10-10 | Chemokine rezeptor |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1224222B1 (de) |
JP (1) | JP4754143B2 (de) |
AT (1) | ATE457317T1 (de) |
AU (1) | AU783776B2 (de) |
CA (1) | CA2387018C (de) |
DE (1) | DE60043823D1 (de) |
DK (1) | DK1224222T3 (de) |
ES (1) | ES2339326T3 (de) |
WO (1) | WO2001027146A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE39849E1 (en) | 1999-10-12 | 2007-09-18 | Chemocentryx, Inc. | Methods for identifying modulators of CCX CKR activity |
US6835547B1 (en) | 1999-10-12 | 2004-12-28 | Chemocentryx, Inc. | Methods for identifying modulators of CCX CKR activity |
WO2001066598A2 (en) * | 2000-03-03 | 2001-09-13 | Icos Corporation | Chemoattractant receptor characterization and cell selection materials and methods and chemokine receptor ccr11 materials and methods |
AU2003250221A1 (en) * | 2002-08-19 | 2004-03-11 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 6(cxcr6) |
US20050176073A1 (en) * | 2004-02-06 | 2005-08-11 | Chemocentryx, Inc. | Cell proliferation associated with CCX CKR expression |
US20050208595A1 (en) * | 2004-03-19 | 2005-09-22 | Brown Arthur M | High throughput assay systems and methods for identifying agents that alter expression of cellular proteins |
CN100342017C (zh) | 2004-05-10 | 2007-10-10 | 中国医学科学院肿瘤医院肿瘤研究所 | 基因重组趋化抗原疫苗 |
CN110251674A (zh) | 2012-09-06 | 2019-09-20 | 阿德莱德研究创新有限公司 | 预防和/或治疗转移性癌症的产品和方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US5055556A (en) | 1981-10-06 | 1991-10-08 | The Board Of Trustees Of The Leland Stanford Jr. Univ. | Fluorescent conjugates for analysis of molecules and cells |
US5093245A (en) | 1988-01-26 | 1992-03-03 | Applied Biosystems | Labeling by simultaneous ligation and restriction |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
JPH02307059A (ja) | 1989-05-23 | 1990-12-20 | Seiko Instr Inc | 反応容器 |
US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
EP0814159B1 (de) | 1990-08-29 | 2005-07-27 | GenPharm International, Inc. | Transgene Mäuse fähig zur Produktion heterologer Antikörper |
US5714350A (en) | 1992-03-09 | 1998-02-03 | Protein Design Labs, Inc. | Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region |
GB2273932A (en) | 1992-11-24 | 1994-07-06 | Stiefel Laboratories | Stable oligonucleotides |
US5514555A (en) | 1993-03-12 | 1996-05-07 | Center For Blood Research, Inc. | Assays and therapeutic methods based on lymphocyte chemoattractants |
US5563762A (en) | 1994-11-28 | 1996-10-08 | Northern Telecom Limited | Capacitor for an integrated circuit and method of formation thereof, and a method of adding on-chip capacitors to an integrated circuit |
EP0899332A3 (de) * | 1997-08-15 | 2000-07-05 | Smithkline Beecham Corporation | G-Protein gekoppelter Rezeptor HFIAO41 |
US5932445A (en) * | 1997-11-07 | 1999-08-03 | Incyte Pharmaceuticals, Inc. | Signal peptide-containing proteins |
JP2002241399A (ja) * | 1997-12-24 | 2002-08-28 | Asahi Kasei Corp | 7回膜貫通型受容体蛋白質et240 |
AU3749499A (en) * | 1998-04-16 | 1999-11-01 | Millenium Pharmaceuticals, Inc. | Novel molecules of the bgckr-related protein family and uses thereof |
JP2003534765A (ja) * | 1998-11-04 | 2003-11-25 | カイロン コーポレイション | 単離されたvshk−1レセプターポリペプチドおよびそれを使用する方法 |
US6620615B1 (en) * | 1999-04-23 | 2003-09-16 | Curagen Corporation | G-protein coupled receptor—encoding nucleic acids |
US9715915B2 (en) | 2014-10-30 | 2017-07-25 | Samsung Electronics Co., Ltd. | Magneto-resistive devices including a free layer having different magnetic properties during operations |
-
2000
- 2000-10-10 AT AT00973455T patent/ATE457317T1/de not_active IP Right Cessation
- 2000-10-10 ES ES00973455T patent/ES2339326T3/es not_active Expired - Lifetime
- 2000-10-10 AU AU11959/01A patent/AU783776B2/en not_active Ceased
- 2000-10-10 JP JP2001530364A patent/JP4754143B2/ja not_active Expired - Fee Related
- 2000-10-10 EP EP00973455A patent/EP1224222B1/de not_active Expired - Lifetime
- 2000-10-10 WO PCT/US2000/028067 patent/WO2001027146A2/en active IP Right Grant
- 2000-10-10 DK DK00973455.9T patent/DK1224222T3/da active
- 2000-10-10 DE DE60043823T patent/DE60043823D1/de not_active Expired - Lifetime
- 2000-10-10 CA CA002387018A patent/CA2387018C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU1195901A (en) | 2001-04-23 |
AU783776B2 (en) | 2005-12-01 |
DK1224222T3 (da) | 2010-05-17 |
EP1224222A2 (de) | 2002-07-24 |
CA2387018A1 (en) | 2001-04-19 |
JP4754143B2 (ja) | 2011-08-24 |
WO2001027146A2 (en) | 2001-04-19 |
JP2003512028A (ja) | 2003-04-02 |
ATE457317T1 (de) | 2010-02-15 |
WO2001027146A9 (en) | 2002-05-10 |
ES2339326T3 (es) | 2010-05-19 |
CA2387018C (en) | 2008-02-12 |
WO2001027146A3 (en) | 2001-11-22 |
EP1224222B1 (de) | 2010-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69841038D1 (de) | ||
WO2003002717A3 (en) | Biological activity of ak155 | |
EP0668075A3 (de) | Nicht-peptidische Tachykininrezeptorantagonisten. | |
WO2001042288A3 (en) | G-protein coupled receptors | |
DE69709561D1 (de) | Östrogen-Rezeptor | |
ZA9810685B (en) | Thrombin receptor antagonists. | |
WO1999020747A3 (en) | HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS | |
DE60043823D1 (en) | Chemokine rezeptor | |
WO2001087937A3 (en) | G-protein coupled receptors | |
EP1292678B8 (de) | G-protein gekoppelte rezeptoren | |
AU2023499A (en) | Pth receptor and screening assay utilizing the same | |
WO1999033981A3 (en) | Human signal peptide-containing proteins | |
MX9802730A (es) | Agonistas receptores hematopoyeticos multifuncionales. | |
AUPN646795A0 (en) | Neuropeptide Y-Y5 receptor | |
WO2000021986A3 (en) | Matrix-remodeling genes | |
WO2001072836A3 (en) | G-protein coupled receptors | |
WO1999041387A3 (en) | Prostate-associated serine protease | |
WO2002026825A3 (en) | G-protein coupled receptors | |
WO2000003005A3 (en) | Human checkpoint kinase | |
WO2001066742A3 (en) | G-protein coupled receptors | |
WO2000040722A3 (en) | Insulin-synthesis genes | |
WO2002002757A3 (en) | Adenylyl and guanylyl cyclases | |
WO1999015659A3 (en) | Human ubiquitin-conjugating enzymes | |
WO2000028034A3 (en) | Cytokine signal regulators | |
WO2001094415A3 (en) | Nuclear hormone receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |